Puma biotechnology press release top
Puma biotechnology press release top
Puma biotechnology press release top
Puma biotechnology press release top
Puma biotechnology press release top
Puma biotechnology press release top

Puma biotechnology press release top

Puma biotechnology press release top, Puma Biotechnology Reports Inducement Award Under Nasdaq Listing top

$43.00

SKU: 7441422

Colour
  • Puma Biotechnology Presents Interim Results of Phase II CONTROL
  • Puma Biotech starts phase II trial for lung cancer therapy By
  • A Top Puma Bio Exec Resigns Ahead of FDA Panel Analysts Defend
  • EX 99.1
Out of stock
Personalised:
: ( x )
Personalisation:
Edit
Remove Personalisation
Frasers Plus

Buy now.

Pay later.

Earn rewards

Representative APR: 29.9% (variable)

Credit subject to status. Terms apply.

Missed payments may affect your credit score

FrasersPlus